Dow Up 0.07% Nasdaq Up 0.61%

Merrimack Pharmaceuticals, Inc. (MACK)

-NasdaqGM
9.76 0.23(2.41%) Nov 26, 4:00PM EST
Prev Close:9.53
Open:9.50
Bid:8.28 x 1000
Ask:N/A
1y Target Est:13.83
Beta:1.23
Earnings Date:Feb 25 - Mar 2 (Est.)
Day's Range:9.41 - 9.82
52wk Range:3.70 - 9.82
Volume:1,850,111
Avg Vol (3m):2,215,900
Market Cap:1.03B
P/E (ttm):N/A
EPS (ttm):-1.03
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for MACK

Comparison

Symbol% ChgMkt Cap
MACKUp 2.41%1.03B
IMMU383.71M
LRUSFN/A
THLD184.49M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):13.16
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.87
Quarterly EPS Est (Dec-14) :-0.19
Mean Recommendation*:1.6
PEG Ratio (5 yr expected):-1.96

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Merrimack Pharmaceuticals, Inc., a biopharmaceutical company, is engaged in discovering, developing, and preparing to commercialize medicines paired with companion diagnostics for the treatment of cancer primarily in the United States. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback